Navigation Links
GlaxoSmithKline launches diabetes and cancer drugs

GlaxoSmithKline is in a spree of producing new diabetes and cancer drugs which it hopes will increase its sales this year. After the recent U.S. drug approvals it is starting // to market two of its new diabetes drug Avandaryl and Avandamet which is found to be effective in treating type 2 diabetes.

The drug Avandaryl is manufactured by combining the two drugs Avandina and Sulphonylureas and the drug Avandamet is produced by the combination of Avandina and Metformin. Glaxo drug Hycamtin is found to be effective in improving the quality of life in patients with cancer and is also found to increase the survival rate. Hycamtin is used in treating ovarian cancers is also found to be effective in treating Lung cancer and is also prescribed for treating relapsed small cell lung cancer, The feasibility of using oral hycamtin is being tried by Glaxo as hycamtin is now administered as an infusion.

GlaxoSmithKline is developing new drugs for cancer and diabetes and the company feels that its drug in the pipeline would be soon getting its FDA approval and would surely help in the treatment of patients and will have important health advances in treating patients.


'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. GlaxoSmithKline To Cultivate Non-Smoking Environment
3. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
4. FDA Mislead On Asthma Drug By GlaxoSmithKline
5. GlaxoSmithKline Defends Its Products
6. Generic Products Compete With GlaxoSmithKline
7. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
8. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
9. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
10. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
11. GlaxoSmithKline Signs Outsourcing Deal With TCS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
(Date:5/26/2016)... ... 26, 2016 , ... MadgeTech will be showcasing its line of data ... Hampshire at the MadgeTech headquarters. With products sold in more than 100 countries around ... including NASA. , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech ...
(Date:5/26/2016)... Farmingdale, NY (PRWEB) , ... May 26, 2016 ... ... and Hereditary Retinal Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on ... free to the public. , Dr. Maisel, founder of Retina Group of ...
(Date:5/26/2016)... ... ... In an effort to provide hair restoration information to the widest possible audience, Dr. Parsa ... not use the app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, is making ... , Dr. Mohebi says, “The positive response to the Snapchat videos we started last month ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... of healthcare supply chain solutions, today announced the organization has earned its ISO ... international standards and is compliant with all rules and policies associated with ISO ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... May 26, 2016 According to a ... Management Market - U.S. Industry Analysis, Size, Share, Growth, Trends, ... in the U.S. was valued at US$ 5.89 Bn in ... 3.4% from 2015 to 2023 to reach US$ 7.99 Bn ... current and emerging needle free drug delivery devices and the ...
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
(Date:5/26/2016)... May 26, 2016 Since its ... into an essential life science tool for conducting genetic ... BCC Research reveals in its new report that the ... phase, one powered by a range of new applications ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
Breaking Medicine Technology: